Cite
MLA Citation
Amber C. King et al.. “Venetoclax: A First-in-Class Oral BCL-2 Inhibitor for the Management of Lymphoid Malignancies.” Annals of pharmacotherapy, vol. 51, n.d., pp. 410–416. http://access.bl.uk/ark:/81055/vdc_100068719755.0x00000c